483
Patheon Biologics Australia Pty LtdPatheon Biologics Australia Pty Ltd – FDA 483, Oct 17, 2023
Record Details
An FDA inspection of Patheon Biologics Australia Pty. Ltd. in Woolloongabba, Australia, a drug substance manufacturer, revealed significant deficiencies. Observations included a failure to establish the identity and suitability of incoming critical materials and components for drug substance manufacture. Additionally, the firm exhibited inadequate user access controls for electronic data acquisition systems, raising concerns about data integrity.
View Company Profile
ID · 72aa249c-8f41-4da3-8622-8fea898e7c0c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.